T raumatic brain injury (TBI) remains a critical public health challenge (1) . TBIrelated deaths are common, occurring in 19.4 of 100,000 persons annually (1) . Population-based epidemiologic studies of severe TBI report a case fatality of 30% to 54% (2) (3) (4) (5) . For survivors of severe TBI, complete recovery to preinjury levels is uncommon; ϳ60% of survivors have ongoing deficits in the areas of cognitive competency, major activity, and leisure and recreation (6) .
There is evidence to suggest that anemia may be injurious to the brain. Anemia during cardiopulmonary bypass has been associated with worsened neurologic status adults both in children (7) and adults (8) . In patients undergoing chronic hemodialysis, Pickett et al (9) showed that normalizing hematocrit (40% to 45%) with the use of additional recombinant human erythropoietin results in improvement in neurocognitive function. In patients with TBI, Gopinath et al (10) found that the occurrence of jugular venous desaturation was strongly associated with neurologic outcome, and anemia has been identified as a contributing cause of jugular venous desaturation (11) . Importantly, anemia in patients with TBI has been associated with reduced survival (12) and lower hospital discharge Glasgow Coma Scale (GCS) scores, Glasgow Outcome Scale scores, and Ranchos Los Amigos scores (13) .
Despite the pathophysiological rationale and associative outcome evidence supporting the detrimental effect of anemia on the brain, there is a paucity of evidence supporting the use of transfusion of packed red blood cells to improve outcome. Furthermore, the optimal hemoglobin level is not known. Gaehtgens
Objective: There is evidence to suggest that anemia after severe traumatic brain injury (sTBI) is detrimental. However, there is a paucity of evidence supporting the use of transfusion of packed red blood cells in patients with sTBI. To understand the acute effect of packed red blood cell transfusion on cerebral oxygenation and metabolism in patients with sTBI.
Design (14) suggested that a hematocrit of 42% to 45% will optimize cerebral oxygen delivery in healthy human volunteers. Animal studies have shown that a hematocrit of 30% to 33% gives an optimal balance of viscosity and oxygen carrying capacity (15) . However, randomized controlled trials that define the optimal hemoglobin level in patients with severe TBI do not exist. Thus, no consensus is apparent with respect to transfusion practice in these patients. Furthermore, there is little understanding of the effects of transfusion on cerebral oxygenation and metabolism.
To gain further insight into the optimal transfusion strategy in patients with severe TBI, a prospective clinical study was performed in which the effect of packed red blood cell transfusion on cerebral oxygenation and metabolism was examined.
METHODS
This study was approved by the local research ethics committee, and written informed assent was obtained from the next of kin of all patients.
All patients were admitted to the Neurosciences Critical Care Unit at Addenbrooke's Hospital (Cambridge University Hospitals NHS Foundation Trust), with the diagnosis of severe TBI from January 15, 2003, until July 27, 2005, were screened. The Addenbrooke's Neurosciences Critical Care Unit is a tertiary academic unit comprising 21 adult Neurosciences Critical Care Unit beds serving a referral population of ϳ2.5 million persons. Approximately 120 patients a year are admitted with severe TBI. The study inclusion criteria were as follows: Ͼ16 years; severe TBI (defined as a TBI resulting in a resuscitated GCS score Յ8, intracranial hypertension Ͼ20 mm Hg for greater than 10 minutes, or requiring neurosurgical intervention), and informed assent from the next of kin. The exclusion criteria were active hemorrhage, active coronary ischemia as judged by dynamic ischemic electrocardiogram changes or positive troponin levels not due to myocardial contusion, inability to place cerebral oxygenation monitors, failure to fall below allocated transfusion threshold during intracranial pressure, and brain tissue oxygen monitoring and lack of informed assent from next of kin.
Patients were managed according to Addenbrooke's Neurosciences Critical Care Unit protocols (16) , which include sedation with propofol and fentanyl, paralysis with atracurium, and support of cerebral perfusion pressure to 70 mm Hg. Monitored variables included electrocardiogram, peripheral oxygen saturation, end-tidal carbon dioxide, jugular venous oxygen saturation, arterial blood pressure, and intracranial pressure. Apart from the transfusion intervention, all other aspects of physiology were kept as stable as possible during the study period.
Patients were randomized by computer random number generator to one of three transfusion thresholds: 8, 9, or 10 g/dL. A tissue oxygen monitor (Neurotrend, Codman, Raynham, MA) and cerebral microdialysis catheter (CMA Microdialysis, Solna, Sweden) were placed through a specially designed cranial access device in the nondominant frontal region. When the patients' hemoglobin concentration fell below their assigned threshold, two units of packed red blood cells were transfused, each over 1 hour regardless of assigned transfusion threshold. A 1-hour period of stabilization was observed before final data collection. Physiologic data were recorded and hemoglobin concentration measured at baseline and at 30, 60, 90, 120, and 180 minutes after initiation of transfusion. Continuous physiologic measurements were collected at a frequency of 50 Hz and averaged over 5 minutes centered on the time point of interest. The primary outcome was change in brain tissue oxygen (P bt O 2 ). Secondary outcomes included dependence of baseline hemoglobin concentration and baseline P bt O 2 on the relationship of transfusion and P bt O 2 , and the effect of transfusion on lactate pyruvate ratio (LPR) and brain pH (pH bt ) as markers of cerebral metabolic state.
Statistical Analysis
Analysis of continuous, normally distributed variables within and between groups were undertaken using the appropriate Student's t test. Non-normally distributed continuous variables were analyzed using the MannWhitney U test. Categorical variables were analyzed using Fisher's exact test. A p value of Ͻ0.05 was considered significant. All statistical tests were two-sided. Given the exploratory nature of this analysis, no correction was made for multiple comparisons.
Primary analysis, change in P bt O 2 over change in hemoglobin concentration, was performed using a population-averaged paneldata model developed using a generalized estimating equation variant of the generalized linear method. An exchangeable within-group correlation structure was used. Individual patient regression analysis was used to substantiate the univariable generalized estimating equation analysis. Clinically relevant variables included in the multivariable model were selected a priori by the investigators. Stepwise elimination was not used. Similar procedures were repeated for analysis of changes LPR and pH bt over time. All analyses were performed with Stata Version 8.0 (Stata Corporation, College Station, TX).
RESULTS
Thirty nonconsecutive patients were studied. The characteristics of the patients are presented in Table 1 . Transfusion occurred on median (intraquartile range) day 4 (3, 6) after injury. Patients received a mean (SD) of 551 (58) mL of packed red cells. The systemic and cerebral physiologic measurements during the study period are presented in Table 2 .
Change in Brain Tissue Oxygen. Median (intraquartile range) change in P bt O 2 was 0.07 (Ϫ0.25 to 0.58) kPa. Fifty-seven percent of patients experienced an increase in P bt O 2 over the course of the study, whereas in 43% of the patients P bt O 2 either did not change or decreased. Before study, cerebral perfusion pressure, PaO 2 , probe location, age, GCS, time of transfusion from injury, pH bt , PaCO 2 , and 
76).
Post hoc analysis revealed a significant interaction between the change in hemoglobin concentration and baseline LPR in the prediction of change in P bt O 2 (p ϭ 0.023 for the interaction term). LPR greater than 25 is a commonly used threshold value indicative of ischemia. For those with a baseline LPR less than 25, the predicted change in P bt O 2 per unit change in hemoglobin concentration was Ϫ0.001 kPa/(g/dL); 95% CI Ϫ0.11 to 0.11. However, for those with a baseline LPR greater than 25, P bt O 2 increased significantly ͓0.18 kPa/(g/dL); 95% CI 0.06 -0.31͔. Unlike the described modifying effects of baseline LPR on change in P bt O 2 with transfusion, baseline LPR did not modify the change in LPR with transfusion. No significant change in pH bt occurred during the study period.
DISCUSSION
These data are the first to prospectively describe the acute effect of red blood cell transfusion on cerebral oxygenation and metabolism in patients with severe TBI. A statistically significant increase in P bt O 2 was demonstrated after transfusion of two units of packed red blood cells. Smith et al (17) found similar results on a review of a longitudinal database of patients with TBI and subarachnoid hemorrhage. In both this study and the study by Smith et al, considerable variability in P bt O 2 response to transfusion was noted, with 43% and 26% of patients experiencing a decline in P bt O 2 , respectively. The interpretation of the data by Smith et al limited by the omission of multivariable analytic techniques required to adjust for factors strongly related to P bt O 2 such as PaO 2 or cerebral perfusion pressure. Importantly, this study is the first to incorporate measures of cerebral cellular metabolism in the assessment of acute transfusion. No beneficial effect of transfusion could be demonstrated in terms of cerebral microdialysate LPR, purportedly a marker of cellular redox state (18) , or pH bt .
The increase in P bt O 2 was most prominent in patients with an LPR greater than 25. Classically, increased LPR has been considered a marker of ischemia, but recent literature suggests LPR to be more accurately described as a marker of mitochondrial dysfunction. Vespa et al (19) correlated LPR with positron emission tomography measures of metabolism of oxygen. They found that LPR most tightly corresponds to nonischemic reduction in the cerebral metabolic rate for oxygen, a measure of mitochondrial oxidative function. P bt O 2 needs to be interpreted as a measure of the balance between oxygen supply and demand (20) . Increased delivery 81 (11) 82 (10) 83 (9) 82 (8) 83 (10) 82 (13) ICP mm Hg mean (SD) 15 (6) 16 (6) 17 (7) 17 (6) 17 (6) 17 (6) PaO 2 (kPa) mean (SD)
14 (2) 14 (2) 14 (3) 14 (3) 14 (3) 14 ( (7) 78 (7) 77 (7) 75 (7) 76 (7) 75 (8 (21) demonstrated that a reduction of hemoglobin level to 6 and 5 g/dL produces subtle, reversible increases in reaction time and impaired immediate and delayed memory in healthy volunteers. As previously mentioned, anemia during cardiopulmonary bypass has been associated with unfavorable neurologic outcomes (7, 8) . Jonas et al (7) performed a randomized clinical trial demonstrating a reduced psychomotor development index in infants undergoing cardiopulmonary bypass at hematocrit values near 22%, compared with patients maintained at hematocrit values near 28%. Habib et al (8) retrospectively reviewed 5,000 adult patients undergoing cardiopulmonary bypass. Neurologic injury (permanent stroke, coma) was more frequently experienced as lowest hematocrit increased. Experimentally, acute hemodilutional anemia accentuated cerebral tissue hypoxia after fluid percussion injury in rats (22) . In pigs after fluid percussion TBI, Gibson (23) found that resuscitation with blood compared with saline was superior in terms of intracranial pressure and survival. In patients with severe TBI, low hematocrit has also been associated with detrimental outcomes. Alvarez et al (12) has described a four-fold increase in the odds of death in patients with severe TBI who experienced a hematocrit Ͻ30%. Carlson et al (13) found lowest hematocrit was associated with lower discharge GCS scores and long-term lower Glasgow Outcome Scale scores in 169 patients with severe TBI.
Despite the convincing evidence indicating that anemia is associated with negative neurologic outcome, there is little support for the correction of anemia in these patients with transfusion of packed red blood cells. McIntyre performed a subgroup analysis of 67 patients with moderate to severe TBI in Transfusion Triggers in Critical Care trial (24) that did not reveal a statistically significant difference in 30-day mortality (liberal 13%, 17% restrictive, p ϭ 0.64) or multiple organ dysfunction (25) . The study by Carlson et al (13) suggested that although low hematocrit was associated with unfavorable neurologic outcome, regression analysis showed that more days with hematocrit Ͻ30% were associated with improved neurologic outcomes. Transfusion was significantly associated with all lower outcome scores on discharge. Thus, although anemia may be harmful to the brain, transfusion may be associated with additional risk. Taken in context with the results of this study, these data question the use of transfusion in those stable patients with TBI.
This study has limitations that warrant discussion. The study period was relatively short. After transfusion, ϳ25% to 30% of prestorage 2,3-diphosphoglycerate may be restored in donor erythrocytes with resultant improvement in oxygen delivery (26) . It must also be acknowledged that the P bt O 2 and microdialysis monitors sample a relatively small portion of brain (ϳ1.5 cm 2 ) that may not be representative of whole brain metabolism. Finally, the nonconsecutive nature of patient selection potentially limits generalizability of the results.
CONCLUSIONS
Transfusion of packed red blood cells acutely results in improved brain tissue oxygen without appreciable effect on cerebral metabolism as measured by LPR or pH bt . The improvement in brain tissue oxygenation is primarily seen in those with deranged cerebral metabolic status at baseline. These data suggest that a reevaluation of transfusion practice in patients with severe TBI is warranted. 
